| Name | 2C-B-BZP (dihydrochloride)
|
|---|
| Formal Name | 1-[(4-bromo-2,5-dimethoxyphenyl)methyl]-piperazine,dihydrochloride |
|---|
| SMILES | BrC1=CC(OC)=C(CN2CCNCC2)C=C1OC.Cl.Cl |
|---|
| InChI Key | FNDWKKCHLQJPIL-UHFFFAOYSA-N |
|---|
| InChI Code | InChI=1S/C13H19BrN2O2.2ClH/c1-17-12-8-11(14)13(18-2)7-10(12)9-16-5-3-15-4-6-16;;/h7-8,15H,3-6,9H2,1-2H3;2*1H |
|---|
| Description | 2C-B-BZP is a designer drug analogue of the US DEA Schedule I controlled stimulant BZP (Nbenzylpiperazine).(1,2) 2C-B-BZP differs from BZP in that the phenyl ring has methoxy groups in the 2 and 5 positions and a bromine in the 4 position.(3) The specific 2,5-dimethoxy-4-bromo substitution pattern on the phenyl ring is also a key feature of the US DEA Schedule I controlled psychedelic phenethylamine 2C-B.(4) The name ”2C-B-BZP” reflects the fact that this designer drug contains key structural motifs from the two highly psychoactive controlled substances. The structure of 2C-B-BZP was elucidated in 2009 after it was detected in seized illicit drug products in Germany.(3) References: (1) Forensic Science International, 121, 47-56, 2001. (2) Neuropsychopharmacology, 30, 550-560, 2005. (3) Forensic Science International, 187, 87-96, 2009. (4) Br. J. Pharmacol. 141(7), 1167-1174, 2004. |
|---|
Status |
Verified |
|---|
| Submitted | 2015-04-01 |
|---|
| Submitted By | Cayman Chemical
Georgia Bureau of Investigation, Headquarters Laboratory – Decatur, GA |
|---|
| Published | 2015-07-16 |
|---|
| Contact | Paul D. Kennedy, PhD. at Cayman Chemical |
|---|
| Product Details | Link |
|---|
Monograph |
Download the 2C-B-BZP (dihydrochloride)
Monograph |
|---|
|
|
